Squamous Cell Carcinoma of Head and Neck
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients [Phase 2]
A Phase 2 trial evaluating camrelizumab in combination with cetuximab and chemotherapy for relapsed/metastatic squamous cell carcinoma of th…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer [Phase 1]
A Phase 1 study evaluating Xevinapant in combination with radiation and chemotherapy for head and neck cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers [Phase 1]
Phase 1 study assessing safety and early efficacy of KFA115 alone and in combination with pembrolizumab in select advanced cancers; the tria…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours [Phase 1]
A Phase 1 study of [225Ac]-FPI-2059 in adults with solid tumours was terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) [Phase 2]
Merck completed a Phase 2 trial (MK-7684A-005) evaluating MK-7684A with or without other anticancer therapies in selected solid tumors.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies [Phase 1]
Phase 1 study evaluating REGN6569 in combination with cemiplimab in adults with advanced solid tumors, including head and neck squamous cell…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer [Phase 2]
A Phase 2 trial of ALKS 4230 (nemvaleukin alfa) in combination with pembrolizumab for head and neck squamous cell carcinoma has completed en…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC [Phase 2]
Phase 2 trial evaluating toripalimab in combination with cetuximab and chemotherapy for conversion therapy in locally nonresectable oral cav…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of GEN1044 (DuoBody-CD3x5T4) in malignant solid tumors has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN) [Phase 1, Phase 2]
A clinical trial update for docetaxel albumin-bound with nivolumab in head and neck squamous cell carcinoma (Phase 1/2) with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy [Phase 1]
A Phase 1 trial of INC280 (capmatinib) in combination with Cetuximab in MET-positive adult patients with metastatic colorectal cancer or hea…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck [Phase 2]
This phase 2 clinical trial evaluated the response rate to a combination of docetaxel and cisplatin in unresectable locally advanced squamou…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck [Phase 2]
A randomized Phase 2 pharmacokinetic trial evaluated chemotherapy with or without panitumumab in metastatic/recurrent squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck [Phase 2]
Phase 2 clinical trial evaluating pemetrexed as salvage therapy for squamous cell carcinoma of the head and neck; current status is unknown …
-
CLINICAL_TRIALS trial_result · 2012-11-22Clinical Trial Update: Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating the safety and efficacy of P276-00 in combination with radiation for advanced head and neck cancer.